Compare BTU & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTU | OPCH |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | 6600 | N/A |
| Industry | Coal Mining | Medical/Nursing Services |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.9B |
| IPO Year | 2001 | 1996 |
| Metric | BTU | OPCH |
|---|---|---|
| Price | $32.68 | $29.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $31.71 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 2.5M | 1.8M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | N/A | ★ 1.27 |
| Revenue | $3,861,500,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $18.45 | $7.53 |
| Revenue Next Year | $5.84 | $8.58 |
| P/E Ratio | ★ N/A | $23.25 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $9.61 | $24.24 |
| 52 Week High | $39.95 | $36.80 |
| Indicator | BTU | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 27.99 |
| Support Level | $32.29 | $29.23 |
| Resistance Level | $39.18 | $31.14 |
| Average True Range (ATR) | 1.78 | 1.27 |
| MACD | -0.14 | -0.50 |
| Stochastic Oscillator | 36.66 | 10.68 |
Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. The Seaborne Thermal segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan, and other regions.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.